CME Medical Symposium: Updates on clinical evidence and international guideline for TROP2-targeting ADC in the treatment of advanced/metastatic triple-negative breast cancer

Coming Soon

8:00 – 12 September 2026

Auditorium, 3rd Floor, F Building, FV Hospital

To provide the latest updates in this field and create a forum for professional exchange among experts, FV Hospital is organising the CME Medical Symposium “Updates on clinical evidence and international guideline for TROP2-targeting ADC in the treatment of advanced/metastatic triple-negative breast cancer”, with details as follows:

• Time: 08:00 – 13:00 | Saturday, 12 September 2026
• Venue: Auditorium, 3^rd Floor, Building F, FV Hospital
• Participation fee: Free of charge
• CME: 1.5 CME credits will be awarded to participants who attend at least 70% of the programme and achieve a post-test score of at least 70%.

The symposium will focus on updates from ESMO and ASCO 2026, clinical data on TROP2-targeting ADCs, adverse event management, and key considerations for applying these therapies in clinical practice.

The programme will feature experts from Cho Ray Hospital and FV Hospital, who will share the latest clinical updates and practical perspectives on the treatment of advanced/metastatic triple-negative breast cancer.

• Dr Le Tuan Anh, PhD – Director of the Oncology Center, Cho Ray Hospital
• Dr Vo Kim Dien, MSc – Deputy Head of Hy Vong Cancer Centre, FV Hospital
• Dr Vo Thi Phuong Thao, MSc – Senior Consultant Oncologist, Hy Vong Cancer Centre, FV Hospital
• Pharmacist Nguyen Thi Khanh Van, MSc – Clinical Pharmacist Supervisor, FV Hospital

We warmly invite doctors, pharmacists and healthcare professionals to attend this CME medical symposium to learn about the latest evidence on TROP2-targeting ADCs and discuss their potential application in the treatment of advanced/metastatic triple-negative breast cancer.

Registration:

To register for the programme, please visit: https://forms.gle/Zxja8nhyfhaLpakE7

CME certificates will be issued to healthcare professionals who attend the full programme and meet the requirements set by the Organising Committee.

Agenda

Speaker Profiles

Dr Le Tuan Anh, PhD

Speaker Information

Dr Le Tuan Anh, PhD, Director of the Oncology Center, Cho Ray Hospital. With more than 20 years of specialised experience in the multimodal diagnosis and treatment of cancer, including breast, lung and gastrointestinal cancers, he has undertaken professional training in Singapore and Australia. He is one of the pioneers in Vietnam in applying advanced radiotherapy techniques, radiosurgery, biological therapies, targeted therapies and immunotherapy. He is committed to optimising personalised treatment approaches to improve treatment outcomes and patients’ quality of life.

Dr Vo Kim Dien, MSc

Speaker Information

Dr Vo Kim Dien, MSc, Deputy Head of Hy Vong Cancer Centre, FV Hospital. He has more than 35 years of experience in medical oncology and radiotherapy. He has extensive expertise in cancer radiotherapy, with particular experience in the treatment of breast cancer, gynaecological cancers, and head and neck cancers.

Dr Vo Thi Phuong Thao, MSc

Speaker Information

Dr Vo Thi Phuong Thao, MSc, Senior Consultant, Hy Vong Cancer Centre, FV Hospital. She is a distinguished young specialist in medical oncology, with expertise in systemic cancer treatment and immunotherapy. She was also awarded the prestigious ESMO Fellowship, enabling her to undertake professional training at The Christie in the United Kingdom, one of Europe's leading cancer treatment centres.

Pharmacist Nguyen Thi Khanh Van, MSc

Speaker Information

Pharmacist Nguyen Thi Khanh Van, MSc, Clinical Pharmacist Supervisor, FV Hospital. She has extensive experience in comprehensive medication safety management, from reviewing electronic medication orders, compounding and dispensing to monitoring and evaluating treatment effectiveness and drug concentrations. Alongside her clinical work, she actively participates in medical and pharmaceutical research projects and delivers professional presentations on optimising medication use for specific patient populations.